Condition
Trypanosoma Cruzi Infection
Total Trials
3
Recruiting
0
Active
0
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 3 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
2Total
P 2 (2)
Trial Status
Completed2
Enrolling By Invitation1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (3)
Showing 3 of 3 trials
NCT07033325Enrolling By Invitation
University-Based Chagas Testing in Salta Province, Argentina
NCT03981523Phase 2CompletedPrimary
New Therapies and Biomarkers for Chagas Infection
NCT03191162Phase 2Completed
Evaluation of Different Benznidazole Regimens for the Treatment of Chronic Chagas Disease.
Showing all 3 trials